Skip to main content
Article
Trial in Progress: A Phase I/II Study of Lintuzumab-Ac225 in Older Patients with Untreated Acute Myeloid Leukemia
Clinical Lymphoma, Myeloma & Leukemia (2017)
  • Joseph G. Jurcic, Columbia University Medical Center
  • Moshe Levy, Texas Oncology
  • Jae Park, Memorial Sloan Kettering Cancer Center
  • Farhad Ravandi, University of Texas MD Anderson Cancer Center
  • Alexander Perl, University of Pennsylvania
  • John Pagel, Cancer Institute
  • B. Douglas Smith, Johns Hopkins University
  • Johnnie Orozco, University of Washington
  • Elihu Estey, University of Washington
  • Hagop Kantarjian, University of Texas MD Anderson Cancer Center
  • David Scheinberg, Memorial Sloan Kettering Cancer Center
  • Laura Finn, Ochsner Medical Center
  • Sharif Khan
  • Gerhard Hildebrandt, University of Kentucky
  • Michael Craig, West Virginia University
  • Ehab Atallah, Medical College of Wisconsin
  • Irma Molina
  • Dragan Cicic
  • Gregory Bergonio
  • Mark Berger, Fred Hutchinson Cancer Research Center
Publication Date
January 9, 2017
DOI
10.1016/j.clml.2017.07.056
Citation Information
Joseph G. Jurcic, Moshe Levy, Jae Park, Farhad Ravandi, et al.. "Trial in Progress: A Phase I/II Study of Lintuzumab-Ac225 in Older Patients with Untreated Acute Myeloid Leukemia" Clinical Lymphoma, Myeloma & Leukemia Vol. 17 (2017)
Available at: http://works.bepress.com/john-pagel/30/